Nextech Systems and Iagnosis to Showcase New Exclusive Partnership During the American Academy of Dermatology Annual Meeting

TAMPA, FL--(Marketwired - March 20, 2015) - Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, today announced its exclusive partnership with Iagnosis, a leading telemedicine provider of online dermatology solutions. Iagnosis provides a teledermatology platform that facilitates patients receiving quality skincare from board-certified dermatologists utilizing computers, tablets and smartphones. Patients takes pictures and provide appropriate medical information online, submitting their case to board certified dermatologists in a convenient manner and receiving diagnosis generally within 12 hours. Through this new partnership, Nextech clients will be able to integrate the patient experience and documentation from these online visits into their Patient Portal and EMR thereby maintaining a complete patient record.

"The exclusive partnership of Nextech and Iagnosis provides the optimal solution for dermatologists looking to improve patience convenience and acquire new patients through online patient engagement," states Christina Majeed, chief product officer of Nextech. "We are thrilled to be leading the way in terms of offering innovative and interoperable new options for doctors to generate additional practice revenue and improve patient experience through the Nextech and Iagnosis solutions."

Committed to HIPAA compliance and the security of PHI, both Nextech and Iagnosis look to streamline the compliant sharing of clinical information from their market leading technology solutions. Both companies provide for private labeling of their portal solutions thus providing a patient engaging interface that is practice specific -- thus allowing dermatologists to personalize their online presence to match that of their practice. 

"We are excited to be partnering with Nextech, who is an all-in-one EMR and practice management solutions provider which understands that patient care and volume are of paramount concern for dermatologists in this era of declining reimbursements," states Dave Zynn, president and CEO of Iagnosis. "Collaboratively, we are committed to enhancing the productivity and profitability of the dermatologists we serve."

Both companies are longtime supporters of the American Academy of Dermatology Annual Meeting. Nextech in booth #328 and Iagnosis in booth #7346 will be showcasing their integration and dermatology specific solutions in San Francisco this weekend.

About Iagnosis

Iagnosis is a leading technology provider of online dermatology solutions. Through its best-in-class platform, Iagnosis provides convenient 24/7 access to affordable, high quality medical care staffed by a broad network of board-certified dermatologists. Its flagship teledermatology product, DermatologistOnCall.com, offers patients a diagnosis, electronic prescription and treatment plan that includes counseling on the condition. Iagnosis has been recognized in the industry for its innovation and actively partners with physician practices, health systems and other organizations to provide comprehensive online skin care solutions to their patients. For more information, visit www.iagnosis.com.

About Nextech

Nextech deploys specialty-focused, intelligent, all-in-one healthcare solutions and services for physician practices. Dedicated to specialty providers since 1997, Nextech delivers consultative guidance, professional services and innovative tools that enable clients to increase efficiencies while meeting their long-term business goals. In 2013, Nextech acquired MDIntelleSys, the cloud based solution provider of IntelleChart. The company's combined portfolio integrates seamlessly with value-added modules to create a single, intelligent, intuitive platform that streamlines clinical, administrative, financial and marketing workflows. To learn how Nextech's advanced offerings help specialty providers succeed in a fast-changing healthcare environment, visit www.nextech.com.